Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-21 Caffo Nathan Chief Business Officer Conversion +10,529 11,254
2020-07-21 Caffo Nathan Chief Business Officer Conversion · Series B Convertible Preferred Stock −10,529 0
2020-07-16 Caffo Nathan Chief Business Officer Grant or award · Employee Stock Option (right to buy) +22,794 22,794

Page 1 of 1 · 3 trades